Cargando…
Lessons Learned from Pompe Disease Newborn Screening and Follow-up
In 2015, Pompe disease became the first lysosomal storage disorder to be recommended for universal newborn screening by the Secretary of the U.S. Department of Health and Human Services. Newborn screening for Pompe has been implemented in 20 states and several countries across the world. The rates o...
Autores principales: | Klug, Tracy L., Swartz, Lori B., Washburn, Jon, Brannen, Candice, Kiesling, Jami L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422965/ https://www.ncbi.nlm.nih.gov/pubmed/33073009 http://dx.doi.org/10.3390/ijns6010011 |
Ejemplares similares
-
Newborn Screening for Pompe Disease
por: Sawada, Takaaki, et al.
Publicado: (2020) -
At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn Screening
por: Lukacs, Zoltan, et al.
Publicado: (2020) -
Validation and Implementation of a Highly Sensitive and Efficient Newborn Screening Assay for Mucopolysaccharidosis Type II
por: Bilyeu, Heather, et al.
Publicado: (2020) -
Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I
por: Dorley, M. Christine, et al.
Publicado: (2023) -
Development of Newborn Screening for Pompe Disease
por: Hwu, Wuh-Liang, et al.
Publicado: (2020)